<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2578">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02518243</url>
  </required_header>
  <id_info>
    <org_study_id>14-PP-08</org_study_id>
    <nct_id>NCT02518243</nct_id>
  </id_info>
  <brief_title>Safe &amp; Easy for Alzheimer's Disease and Related Pathologies</brief_title>
  <acronym>SaFEE2</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      All over the world the increasing prevalence of chronic disorders and its impact on&#xD;
      functional decline is challenging the sustainability of health care systems. Older&#xD;
      individuals also frequently experience the reversible &quot;frailty syndrome&quot;, which overlaps with&#xD;
      chronic diseases, increasing incidence of disability.&#xD;
&#xD;
      Building a global system aiming to take in charge all causes leading to loss of autonomy is a&#xD;
      rather complicated task involving numerous Information and Communication technologies (ICT)&#xD;
      solutions which are not always easy to use in everyday life.&#xD;
&#xD;
      The SafEE (Safe Easy Environment) project aim is to improve the safety, autonomy and quality&#xD;
      of life of older people at risk.&#xD;
&#xD;
      The SafEE2 project develop non pharmacological therapeutic through diferent ICT (stimulation&#xD;
      aromatherapy automatic fragrance ...) .&#xD;
&#xD;
      The goal of this study is to validate the acceptability, sensitivity and efficacy of the&#xD;
      systems.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The non pharmacological therapeutic will be install at hospital room :&#xD;
&#xD;
        -  aromatherapy,&#xD;
&#xD;
        -  music therapy,&#xD;
&#xD;
        -  cognitive training in multimedia application offering cognitive games.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tolerance of the systems set up and use frequency evaluated using the Caregiver Questionnaire</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">14</enrollment>
  <condition>Cognitive Deterioration</condition>
  <arm_group>
    <arm_group_label>Alzheimer's Disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient's answer with non pharmacological therapeutic</intervention_name>
    <description>Installation at patient's home of :&#xD;
aromatherapy&#xD;
music therapy&#xD;
cognitive training in multimedia application offering cognitive games</description>
    <arm_group_label>Alzheimer's Disease</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects with a diagnosis of Alzheimer's disease according to NINCDS-ADRDA (McKhann,&#xD;
             Drachman et al. 1984) or typical or atypical Alzheimer's disease (Dubois B. et al.&#xD;
             2007).&#xD;
&#xD;
          -  Score at Mini Mental Test (MMSE) â‰¥16.&#xD;
&#xD;
          -  Subjects residing in nursing homes.&#xD;
&#xD;
          -  Subjects beneficiaries of a social security scheme.&#xD;
&#xD;
          -  Signature of free and informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Failure to pass the neuropsychological tests because of a sensory or motor deficit.&#xD;
&#xD;
          -  Sensory deficit (olfactory or visual) preventing the patient made perfectly meet the&#xD;
             therapeutic solutions.&#xD;
&#xD;
          -  Prescription of a new treatment psychotropic (hypnotic, anxiolytic, antidepressant,&#xD;
             antipsychotic) in the week before the evaluation;&#xD;
&#xD;
          -  Persons deprived of liberty (administrative or judicial).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renaud DAVID, MD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Nice</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ehpad Valrose</name>
      <address>
        <city>Nice</city>
        <zip>06100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>July 7, 2015</study_first_submitted>
  <study_first_submitted_qc>August 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2015</study_first_posted>
  <last_update_submitted>August 5, 2015</last_update_submitted>
  <last_update_submitted_qc>August 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

